NPI: 1699747303 · HILLIARD, OH 43026 · Professional Counselor · NPI assigned 02/06/2006
Authorized official PINCINCE, DEBORAH controls 20+ related entities in our dataset. Read more
| Authorized Official | PINCINCE, DEBORAH (ADMINISTRATOR) |
| NPI Enumeration Date | 02/06/2006 |
Other providers sharing the same authorized official: PINCINCE, DEBORAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 48,551 | $1.86M |
| 2019 | 45,618 | $1.86M |
| 2020 | 85,068 | $1.75M |
| 2021 | 297,609 | $5.94M |
| 2022 | 236,996 | $3.39M |
| 2023 | 116,057 | $506K |
| 2024 | 108,744 | $504K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 96,442 | 87,571 | $3.12M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 44,897 | 42,145 | $2.73M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 51,341 | 47,616 | $2.04M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 33,129 | 32,701 | $1.73M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 123,328 | 114,835 | $1.65M |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 60,971 | 55,939 | $1.30M |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 20,818 | 20,416 | $732K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 12,700 | 11,814 | $307K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 15,885 | 15,465 | $260K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 18,232 | 17,724 | $210K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 9,951 | 9,244 | $192K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2,280 | 2,256 | $180K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 13,082 | 6,407 | $151K |
| 90674 | 4,900 | 4,860 | $107K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,675 | 1,616 | $95K |
| 90746 | 1,346 | 1,337 | $86K | |
| 90715 | 2,588 | 2,562 | $81K | |
| 90707 | 1,071 | 1,064 | $78K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 1,238 | 1,215 | $77K |
| 90686 | 4,302 | 4,262 | $75K | |
| 99401 | 3,057 | 2,990 | $73K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,571 | 1,435 | $65K |
| 0001A | 424 | 421 | $37K | |
| 86580 | 6,520 | 5,865 | $35K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,398 | 2,085 | $31K |
| 90716 | 238 | 237 | $31K | |
| 90682 | 665 | 664 | $31K | |
| 0002A | 293 | 293 | $26K | |
| 0004A | 319 | 318 | $24K | |
| 99201 | 1,067 | 1,023 | $22K | |
| 0031A | 213 | 212 | $19K | |
| 90734 | 271 | 269 | $19K | |
| 0071A | 225 | 223 | $19K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2,054 | 1,694 | $18K |
| 81002 | 7,048 | 6,811 | $16K | |
| 99402 | 453 | 432 | $16K | |
| 90750 | 110 | 110 | $15K | |
| 0011A | 163 | 162 | $15K | |
| 0072A | 146 | 145 | $12K | |
| 0064A | 140 | 140 | $11K | |
| 0081A | 121 | 121 | $11K | |
| 81025 | 1,589 | 1,555 | $10K | |
| 90739 | 72 | 72 | $9K | |
| 0082A | 95 | 95 | $8K | |
| 90619 | 58 | 58 | $7K | |
| 0012A | 76 | 76 | $7K | |
| 99407 | 227 | 223 | $4K | |
| 0124A | 95 | 95 | $4K | |
| 0083A | 42 | 42 | $3K | |
| 36415 | Collection of venous blood by venipuncture | 1,193 | 1,167 | $3K |
| 0134A | 65 | 65 | $2K | |
| 90480 | 37 | 36 | $1K | |
| 82947 | 252 | 248 | $820.97 | |
| 90632 | 12 | 12 | $715.80 | |
| 86308 | 113 | 109 | $480.31 | |
| 90656 | 13 | 13 | $268.20 | |
| 87905 | 25 | 25 | $193.37 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 13 | 12 | $102.16 |
| 86328 | 27 | 27 | $38.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 42 | 42 | $29.01 |
| 90662 | 15 | 15 | $9.84 | |
| 91300 | 153 | 147 | $0.02 | |
| 91301 | 15 | 13 | $0.01 | |
| 3074F | 68,235 | 63,211 | $0.00 | |
| 3008F | 51,169 | 46,972 | $0.00 | |
| 1036F | 78,282 | 71,157 | $0.00 | |
| 3079F | 15,200 | 14,520 | $0.00 | |
| 3080F | 1,653 | 1,607 | $0.00 | |
| 3075F | 5,589 | 5,433 | $0.00 | |
| 91307 | 45 | 43 | $0.00 | |
| 1160F | 57,591 | 51,593 | $0.00 | |
| 3078F | 50,290 | 46,867 | $0.00 | |
| 1159F | 56,192 | 50,383 | $0.00 | |
| 91308 | 178 | 171 | $0.00 | |
| 4004F | 50 | 49 | $0.00 | |
| 3077F | 2,104 | 2,037 | $0.00 | |
| 91312 | 73 | 73 | $0.00 | |
| 91313 | 56 | 56 | $0.00 | |
| 4124F | 35 | 35 | $0.00 |